ArticleFrontiers in immunology2022

Utomilumab in Patients With Immune Checkpoint Inhibitor-Refractory Melanoma and Non-Small-Cell Lung Cancer.

David S Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.